Unknown

Dataset Information

0

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.

ABSTRACT:

SUBMITTER: Tanaka A 

PROVIDER: S-EPMC7844351 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.
| S-EPMC8200307 | biostudies-literature
Unknown Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.
| S-EPMC7343863 | biostudies-literature
Unknown Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance.
| S-EPMC8613670 | biostudies-literature
Unknown Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan.
| S-EPMC8636879 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2 antibodies in South Korea.
| S-EPMC8142885 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
| S-EPMC7588539 | biostudies-literature
Unknown Comparison of Toxoplasma gondii Seroprevalence in Shelter Cats and Dogs during 1999-2001 and 2009-2011 in Tokyo, Japan.
| S-EPMC4540423 | biostudies-other
Unknown SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020.
| S-EPMC8071542 | biostudies-literature
Unknown Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.
| S-EPMC7546957 | biostudies-literature
Unknown Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
| S-EPMC8059683 | biostudies-literature